Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Tragara Pharma received early financing of $40.0M on 2007-03-15.
| Series | Round size | Date |
|---|---|---|
| Series A | $40M | 03/2007 |
| Series Unknown | $5M | 04/2010 |
| Debt Financing | $4M | 08/2012 |
| Series B | $9.4M | 08/2013 |
| Series B | $3M | 04/2014 |
| Convertible Note | $1.3M | 07/2015 |
| Debt Financing | $1.2M | 07/2015 |
| Series C | $4.8M | 08/2015 |
| Series Unknown | $13M | 08/2015 |
| Series Unknown | $3.3M | 11/2016 |
| Investors | Security type |
|---|---|
| Mitsubishi Electric | Series A |
| ProQuest Investments | Series A |
| Morgenthaler Ventures | Series A |
| Oxford Bioscience Partners | Series A |
| Domain Associates | Series A |
| Mitsubishi Motors | Series Unknown |
| ProQuest Investments | Series Unknown |
| Morgenthaler Ventures | Series Unknown |
| Oxford Bioscience Partners | Series Unknown |
| Domain Associates | Series Unknown |
| RMI Partners | Series B |
| RMI Partners | Series B |
| RMI Partners | Convertible Note |
| RMI Partners | Series C |
Tragara Pharma's top competitor, Odonate Therapeutics, earned an annual revenue of $6.3B.
Tragara Pharma's smallest competitor is aTyr Pharma with revenue of $235.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| SABPA | - | $62.0M | 7,500 | - |
| aTyr Pharma | - | $235,000 | 44 | - |
| Histogen | - | $17.8M | 19 | - |
| Otonomy | - | $1.0M | 49 | - |
| AnaptysBio | - | $91.3M | 78 | - |
| Odonate Therapeutics | - | $6.3B | 153 | - |
Zippia gives an in-depth look into the details of Tragara Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Tragara Pharma. The employee data is based on information from people who have self-reported their past or current employments at Tragara Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Tragara Pharma. The data presented on this page does not represent the view of Tragara Pharma and its employees or that of Zippia.
Tragara Pharma may also be known as or be related to TRAGARA PHARM, Tragara Pharma, Tragara Pharmaceuticals Inc and Tragara Pharmaceuticals, Inc.